Prosecution Insights
Last updated: October 02, 2026

Examiner: EISEMAN, LYNSEY C

Tech Center 3700 • Art Units: 1758 3762 3769 3792 3796

This examiner grants 49% of resolved cases

Analysis

Lynsey C. Eiseman handles patent applications in Tech Center 3700 and Art Unit 1758. She has a total of 668 resolved cases, which forms the basis for her performance metrics. Her allowance rate is 49.1 percent, representing the primary probability of success for applications on her docket. This 49.1 percent rate indicates the frequency with which she grants patent applications in her technical field.

The data highlights an interview lift of 39.9 percent, which is a factor for practitioners to consider during prosecution. This 39.9 percent lift indicates that direct communication with the examiner can change the chances of reaching an allowance compared to the baseline rate. Utilizing interviews may be a strategy for resolving outstanding issues in Art Unit 1758.

The median time to reach an allowance is 1608 days. This 1608-day duration provides a benchmark for the expected length of the prosecution process from filing to grant. Practitioners can use this median pendency to help applicants plan their intellectual property strategies and budget for the time required to navigate the examination process under her review.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

49.1%
Allow Rate
-20.9% vs TC avg
714
Total Applications
+39.9%
Interview Lift
1608
Avg Prosecution Days
Based on 668 resolved cases, 2023–2026

Rejection Statute Breakdown

2.4%
§101 Eligibility
18.7%
§102 Novelty
44.8%
§103 Obviousness
29.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18653148 INTRAVASCULAR LITHOTRIPSY DEVICE THAT GENERATES AN ADVANCING ENERGY WAVEFRONT Non-Final OA Boston Scientific Scimed, Inc.
18397395 BALLOON WITH EMITTER FOR INTRAVASCULAR LITHOTRIPSY DEVICE Non-Final OA Boston Scientific Scimed, Inc.
18560754 METHODS AND DEVICES FOR ENABLING ACTIVE MONITORING AND COMMUNICATIONS BETWEEN MEDICAL FIBER OPTIC CATHETERS AND MEDICAL LASER LIGHT SYSTEMS Non-Final OA KONINKLIJKE PHILIPS N.V.
18730129 BLOOD PUMP Non-Final OA Abiomed Europe GmbH
18867662 IMPLANTABLE APPARATUS HAVING HELIX FIXATION WITH VARYING CROSS-SECTION Non-Final OA MEDTRONIC, INC.
18680853 LASER INTRAVASULAR LITHOTRIPSY DEVICE FOR STENOSIS CALCIFIED LESIONS Final Rejection Shockwave Medical, Inc.
18400153 SYSTEMS AND METHODS FOR CONTROLLING LASER TREATMENTS USING REFLECTED INTENSITY SIGNALS Non-Final OA IPG PHOTONICS CORPORATION
18019356 SYSTEMS AND METHODS FOR CONTROLLING LASER TREATMENTS Non-Final OA IPG PHOTONICS CORPORATION
18572463 STIMULATION METHODS FOR AN ELECTROMAGNETICALLY OR ELECTRICALLY CONTROLLED SPONTANEOUS RESPIRATION Final Rejection STIMIT AG
18867486 Methods and Systems for Controlling Blood Pressure Non-Final OA BackBeat Medical, LLC
18867391 LIGHT THERAPY BLANKET Non-Final OA EQUISOL LLC
18228083 OPHTHALMOLOGICAL LASER DEVICE HAVING A LASER SCANNER Final Rejection Ziemer Ophthalmic Systems AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month